Clopidogrel News and Research

RSS
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Study shows best antiplatelet treatment after transcatheter aortic valve implantation

Study shows best antiplatelet treatment after transcatheter aortic valve implantation

Personalized genetic testing helps reduce adverse events following balloon angioplasty

Personalized genetic testing helps reduce adverse events following balloon angioplasty

Precision medicine can determine the best drug treatment for severe heart disease

Precision medicine can determine the best drug treatment for severe heart disease

Study provides indications and techniques of lower extremity revascularization

Study provides indications and techniques of lower extremity revascularization

Clopidogrel added to aspirin and rvaroxaban shows no additional benefit for peripheral artery disease

Clopidogrel added to aspirin and rvaroxaban shows no additional benefit for peripheral artery disease

Clinical trial using genetic testing to guide antiplatelet therapy post-PCI falls short of stated goal

Clinical trial using genetic testing to guide antiplatelet therapy post-PCI falls short of stated goal

Low-dose rivaroxaban reduces adverse heart events in symptomatic PAD post-intervention

Low-dose rivaroxaban reduces adverse heart events in symptomatic PAD post-intervention

Adding antiplatelet therapy to oral anticoagulants raises risk for TAVR patients with atrial fibrillation

Adding antiplatelet therapy to oral anticoagulants raises risk for TAVR patients with atrial fibrillation

Partnership between medical specialties helps improve cardiovascular health

Partnership between medical specialties helps improve cardiovascular health

Edoxaban-based dual therapy noninferior to standard treatment in atrial fibrillation post-stenting

Edoxaban-based dual therapy noninferior to standard treatment in atrial fibrillation post-stenting

People with stroke can take common medicines without raising risk of another stroke

People with stroke can take common medicines without raising risk of another stroke

Scientists solve mystery surrounding mechanical forces that influence blood clotting

Scientists solve mystery surrounding mechanical forces that influence blood clotting

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Study indicates the benefits of stopping aspirin in heart attack patients

Study indicates the benefits of stopping aspirin in heart attack patients

Access to real-time genotype data influences prescriber behavior after PCI

Access to real-time genotype data influences prescriber behavior after PCI

Combination treatment lowers risk of ischemic stroke recurrence

Combination treatment lowers risk of ischemic stroke recurrence

Patients taking anti-depressants more likely to develop gastrointestinal bleeding

Patients taking anti-depressants more likely to develop gastrointestinal bleeding

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Experimental vaccine shows promise to protect stroke survivors from blood clots

Experimental vaccine shows promise to protect stroke survivors from blood clots

Study aims to understand role of clopidogrel in patients with cardiovascular disease

Study aims to understand role of clopidogrel in patients with cardiovascular disease